These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9551042)

  • 1. [Glycyrrhizin for the treatment of allergic diseases and chronic hepatitis].
    Zeuzem S
    Dtsch Med Wochenschr; 1998 Mar; 123(12):372. PubMed ID: 9551042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 3. [New antiviral agents in chronic viral hepatitis].
    Gómez Cedenilla A; Zapater Hernández P; García Buey L; Abad Santos F; García Monzón C; González Mateos F; Moreno Otero R
    Rev Clin Esp; 1998 Feb; 198(2):104-13. PubMed ID: 9558926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycyrrhizic acid].
    Tolstikov GA; Baltina LA; Shul'ts EE; Pokrovskił AG
    Bioorg Khim; 1997 Sep; 23(9):691-709. PubMed ID: 9441592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
    Miyake K; Tango T; Ota Y; Mitamura K; Yoshiba M; Kako M; Hayashi S; Ikeda Y; Hayashida N; Iwabuchi S; Sato Y; Tomi T; Funaki N; Hashimoto N; Umeda T; Miyazaki J; Tanaka K; Endo Y; Suzuki H
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1198-204. PubMed ID: 12453280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic viral hepatitis: the end of the beginning?
    Dusheiko G
    Br J Hosp Med; 1994 Jun 15-Jul 12; 52(1):8-11. PubMed ID: 7524985
    [No Abstract]   [Full Text] [Related]  

  • 8. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis.
    Gentile I; Borgia G
    J Hepatol; 2010 May; 52(5):778. PubMed ID: 20347500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of amixin in the therapy and prevention of some viral infections].
    Zakirov IG
    Klin Med (Mosk); 2002; 80(12):54-6. PubMed ID: 12638414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A meta-analysis of diammonium glycyrrhizinate enteric-coated capsules versus diammonium glycyrrihizinate in patients with chronic viral hepatitis].
    Ling Q; Jin H; Zheng J; Shi G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):411-5. PubMed ID: 25203702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
    Su XS; Chen HM; Wang LH; Jiang CF; Liu JH; Zhao MQ; Ma XH; Zhao YC; Han DW
    J Tradit Chin Med; 1984 Jun; 4(2):127-32. PubMed ID: 6567725
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment and prevention of chronic viral hepatitis].
    Lumio J; Vuoristo M
    Duodecim; 1994; 110(20):1883-92. PubMed ID: 7555802
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon system in viral hepatitis].
    Lisker Melman M
    Rev Invest Clin; 1990 Jul; 42 Suppl():92-6. PubMed ID: 19256144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized therapy in chronic viral hepatitis.
    Brunetto MR; Colombatto P; Bonino F
    Mol Aspects Med; 2008; 29(1-2):103-11. PubMed ID: 18068759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis--various aspects of the problem].
    Ryss EA; Fishzon-Ryss IuI
    Klin Med (Mosk); 1991 Sep; 69(9):6-11. PubMed ID: 1803154
    [No Abstract]   [Full Text] [Related]  

  • 17. New antiviral agents for viral hepatitis: our cup runneth over but is only half full.
    Dienstag JL
    Gastroenterology; 1999 Sep; 117(3):525. PubMed ID: 10464127
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical-epidemiological features, diagnostics, treatment of chronic viral hepatitises, combined with opisthorchosis in inhabitants of Siberia and the Northern regions of Russia.
    Paltsev AI
    Alaska Med; 2007; 49(2 Suppl):153-60. PubMed ID: 17929626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phosphogliv: mechanism of therapeutic action and clinical efficacy].
    Archakov AI; Sel'tsovskiĭ AP; Lisov VI; Tsyganov DI; Kniazhev VA; Ipatova OM; Torkhovskaia TI
    Vopr Med Khim; 2002; 48(2):139-53. PubMed ID: 12189622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
    van Rossum TG; Vulto AG; de Man RA; Brouwer JT; Schalm SW
    Aliment Pharmacol Ther; 1998 Mar; 12(3):199-205. PubMed ID: 9570253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.